Filing metadata

Accession number
0000950170-24-112694
Form type
Form 4
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Oct 03, 2024
Reporting period
Sep 30, 2024
Description
Insider transaction

Explore SEC Filings Hub